Clinical Trials Browser

Phase 1/2 × Carcinoma, Squamous Cell × tremelimumab × Clear all

NCT03784066 2024-07-03

DUTRELASCO

Phase 1/2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT03283605 2024-06-28

Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas

Phase 1/2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell